NCT01133366 - A Study to Determine the Effects of Multiple Doses of Mipomersen (200 mg SC) on the Pharmacodynamics and Pharmacokinetics of Single-dose Warfarin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

May 31, 2010

Study Completion Date

July 31, 2010

Conditions

Healthy

Interventions

DRUG

warfarin sodium

25 mg of warfarin oral (single dose)

DRUG

mipomersen sodium; warfarin sodium

200 mg of mipomersen subcutaneous (SC) (4 doses) plus a single 25 mg of warfarin oral administered with the final mipomersen SC dose

Trial Locations (1)

PPD Development, LP, Austin